Patients Ending the silence: Why the menopause matters in the workpla... One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.
News Neumora laid low by depression trial failure The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.